This House resolution supports the goals and ideals of National Women and Girls HIV/AIDS Awareness Day, observed each year on March 10. It cites U.S. and global statistics about HIV, notes that women make up a significant share of people living with HIV, and says women of color are disproportionately affected. The resolution calls for greater focus on the HIV-related vulnerabilities of women and girls, stronger investment in prevention, care, treatment, and research, and better access to life-saving medicines. It encourages youth-friendly, culturally responsive, and inclusive health services, routine testing, and access to medicines such as pre- and post-exposure prophylaxis and antiretroviral therapy. The resolution also supports U.S. investment in global efforts, foreign assistance to address violence and discrimination, and inclusion of up-to-date, medically accurate HIV information in sexual education.
The resolution expresses the House’s support for the awareness day and urges focus on prevention, care, and education for women and girls affected by HIV. It highlights testing recommendations and the need for access to medications and culturally appropriate services. No publicly available information on direct legal changes or specific funding actions appears in the text of the resolution.
The resolution supports "strong, sustained investment" in prevention, care, treatment, and research for women and girls, but it does not list dollar amounts or create new funding in the text. No publicly available information on costs or new funding is included.
According to the resolution's text, supporters say the House should recognize progress since the start of the epidemic, recommit to bipartisan efforts to end the HIV epidemic, focus on the needs of women and girls (including survivors of violence or discrimination), reduce disparities, improve access to medications and care, and invest in evidence-based global and domestic programs. The text also emphasizes inclusive sexual education and addressing barriers that drive new infections.
No publicly available information on opposition or formal objections is included in the resolution text or provided metadata.